Skip to main content
. 2023 Apr 7;14:1144550. doi: 10.3389/fphar.2023.1144550

TABLE 1.

Baseline characteristics of the study participants.

OEA (n = 30) Placebo (n = 30) p
Age (years) 41.78 (9.77) 42.39 (11.77) 0.839 a
Gender, n (%) 1.00 b
Males 14 (46.66) 14 (46.66)
Females 16 (53.34) 16 (53.34)
Education, n (%) 0.403 b
Illiterate 0 (0) 1 (3.33)
Diploma and lower 23 (76.66) 22 (73.33)
Bachelors and higher 7 (23.34) 7 (23.34)
Employment, n (%)
Employed 19 (63.34) 17 (56.67) 0.207 b
Unemployed 11 (36.66) 13 (43.33)
Marital status, n (%) 0.369 b
Single 3 (10.00) 5 (16.67)
Married 27 (90.00) 25 (83.33)
Physical activity level, n (%)
Very low 12 (40.00) 13 (43.33) 0.419 b
Low 11 (36.66) 9 (30.00)
Moderate and high 7 (23.34) 8 (26.67)
Severity of fatty liver, n (%) 1.00 b
Mild 19 (63.33) 19 (63.33)
Moderate 11 (36.67) 11 (36.67)
Severe 0 (0) 0 (0)

BMI, body mass index.; OEA, oleoylethanolamide.

Age is presented as mean (SD); other variables are presented as number (%).

a

Independent samples t-test.

b

Fisher’s exact test.